Cytosorbents (HQE) Ownership - Who Owns Cytosorbents?
0 Followers
Cytosorbents (HQE) Ownership Overview
- 23.46% Insiders
- 32.44% Mutual Funds
- 1.25% Other Institutional Investors
- 2.93% ETFs
- 39.91% Public Companies and Individual Investors
The ownership structure of Cytosorbents (DE:HQE) stock is a mix of institutional, retail, and individual investors. Approximately 36.63% of the company’s stock is owned by Institutional Investors, 23.46% is owned by Insiders, and 39.91% is owned by Public Companies and Individual Investors.
The ownership structure of Cytosorbents (DE:HQE) stock is a mix of institutional, retail, and individual investors. Approximately 36.63% of the company’s stock is owned by Institutional Investors, 23.46% is owned by Insiders, and 39.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 15, 2026 | Peter Mariani | $44,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Neuberger Berman Equity Funds | 797,640 | Institution | 25.31% | 4,841,675 |
| Peter Mariani | 638,113 | Insider | 20.25% | 3,873,346 |
| BlackRock, Inc. | 627,211 | Institution | 19.90% | 3,807,171 |
| Usaa Mutual Funds Trust | 200,228 | Institution | 6.35% | 1,215,384 |
| Phillip Chan | 100,996 | Insider | 3.21% | 613,046 |
| Vanguard | 92,441 | Institution | 2.93% | 561,117 |
| Morgan Stanley Pathway Funds | 20,132 | Institution | 0.64% | 122,201 |
| Victory Portfolios Iii | 4,302 | Institution | 0.14% | 26,113 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Neuberger Berman Equity Funds | 797,640 | Institution | 25.31% | 4,841,675 |
| Usaa Mutual Funds Trust | 200,228 | Institution | 6.35% | 1,215,384 |
| Morgan Stanley Pathway Funds | 20,132 | Institution | 0.64% | 122,201 |
| Victory Portfolios Iii | 4,302 | Institution | 0.14% | 26,113 |
FAQ
Who Owns Cytosorbents (DE:HQE)?
According to the latest TipRanks data, approximately 36.63% of the company's stock is held by institutional investors, 23.46% is held by insiders, and 39.91% is held by public companies and individual investors.
What percentage of Cytosorbents (DE:HQE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.63% of Cytosorbents (DE:HQE) stock is held by institutional investors: 32.44% by mutual funds, 2.93% by ETFs and 1.25% by other institutional investors.
What percentage of Cytosorbents (DE:HQE) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.91% of Cytosorbents (DE:HQE) stock is held by public companies and individual investors.
Who owns the most shares of Cytosorbents (DE:HQE)?
NEUBERGER BERMAN EQUITY FUNDS owns the most shares of Cytosorbents (DE:HQE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
